Complex formulations require an integrated view of formulation, device, deposition, permeation and in vivo performance.
Biomimetic evaluation brings critical physiological environments into earlier development and supports measurable candidate convergence.
Continuous mapping between in vitro models and in vivo evidence helps identify decisive variables and improve development decisions.